The Chain of Compliance® - Contract Pharma

June 14, 2018

Chain of Compliance® is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses why the Chain of Compliance® is critical to winning in the RMAT market.  Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Chain of Compliance®